Consent Not on File
Appeals stalled because protected records cannot be disclosed without specific patient authorisation.
The fixObtain a properly scoped consent at admission covering payer communication.
Confidentiality respected, testing and medication billed cleanly
Addiction treatment records carry privacy protections stricter than ordinary medical records, which changes what you can disclose in an appeal. Add drug testing under frequency review and medication-assisted treatment with its own rules, and billing gets genuinely constrained. We work inside those limits rather than around them.
Substance abuse treatment billing covers addiction care across levels of intensity. It includes assessment, counselling, medication-assisted treatment, drug testing, and structured programmes from outpatient through residential care.
What sets it apart is confidentiality. Records from certain substance use programmes are protected beyond standard privacy rules, restricting what may be disclosed without specific patient consent, including to payers during an appeal.
That constraint runs through everything. Verification, authorisation, and appeals all have to be handled in a way that respects those limits, which means consent management is part of the billing process rather than a separate compliance task.
You often cannot send a payer the record that would win the appeal without specific consent.
Protected programme records need specific patient consent before being shared, including with payers.
Drug testing frequency and complexity draw scrutiny and must reflect individual clinical need.
Medication-assisted treatment involves prescribing requirements and sometimes bundled programme payments.
Patients move between intensities during treatment, and each move needs its own authorisation.
Privacy law shapes how each of these can be handled.
Appeals stalled because protected records cannot be disclosed without specific patient authorisation.
The fixObtain a properly scoped consent at admission covering payer communication.
Drug testing performed on a fixed programme schedule without individual justification.
The fixDocument individual clinical reasoning for each patient's testing frequency.
Patients moved between intensities without a new authorisation for the new level.
The fixRequest authorisation at every level change, before the change takes effect.
Medication-assisted treatment billed separately when a bundled programme rate applied.
The fixConfirm whether the payer bundles medication into the programme rate.
Programme days billed without documented participation meeting the minimum.
The fixRecord attendance hours daily and verify before any day is billed.
Payer notified after admission, so the first days fall outside the authorised period.
The fixNotify within the required window as part of the admission process.
Consent-aware from verification through appeals.
A properly scoped disclosure consent is obtained at admission so payer communication is possible later.
Coverage is checked and the plan receives admission notice within its own reporting deadline.
Every level of care, including each change during treatment, receives its own authorisation.
Drug testing frequency is tied to documented individual clinical reasoning rather than a programme schedule.
Medication-assisted treatment is billed according to whether the payer bundles it into the programme rate.
Denials are appealed using what consent permits, with reporting on authorised versus delivered days.
Medication-assisted treatment and testing included.
A general view of how addiction treatment is billed.
| Range | What It Covers |
|---|---|
| H0001–H0005 | Assessment, counselling, and behavioural health services |
| H0015 | Intensive outpatient programme services |
| H0018–H0019 | Residential treatment services |
| 80305–80307 | Presumptive drug class screening |
| 99202–99215 | Evaluation and management for medication treatment |
| G2067–G2080 | Opioid treatment programme bundled services |
| Group | Clinical Focus |
|---|---|
| F10 | Alcohol-related disorders |
| F11 | Opioid-related disorders |
| F12 | Cannabis-related disorders |
| F14–F15 | Stimulant-related disorders |
| F19 | Other psychoactive substance disorders |
| Z71.41 | Alcohol abuse counselling and surveillance |
Note: This is general education on how substance abuse rehab coding is organised. Code sets and payer policies change often. Always check the current code set and the payer's active policy for the date of service.
We work inside the platform your centre already runs.
Answers for treatment centres and addiction programmes.
They limit what you can send. Records from protected substance use programmes generally cannot be disclosed to a payer without specific patient consent, which means the clinical detail that would win an appeal may be unavailable. Obtaining a properly scoped consent at admission, covering payer communication, keeps that option open when you need it later.
One specific enough to permit disclosure to payers for authorisation and appeals, and clearly explained to the patient. General medical consent forms are usually insufficient for protected programme records. Getting this right at admission prevents a situation where care was clinically appropriate, funded days were denied, and you cannot lawfully send the evidence.
It will be if testing follows a uniform programme schedule rather than individual clinical need. Reviewers compare testing volume against patient risk, and a centre testing everyone identically regardless of treatment stage stands out immediately. Recording why each patient is tested at their particular frequency, based on history and current stability, is what defends the volume when it is examined.
Each level needs its own authorisation, obtained before the change takes effect. Patients commonly step down from residential to intensive outpatient during treatment, and continuing to bill under the previous authorisation produces denials. Because these transitions are clinically driven and often happen quickly, the authorisation step is easy to miss.
It depends on the payer and the programme structure. Some plans bundle medication and associated services into a single programme rate, while others expect them billed separately. Billing separately against a bundled rate produces denials, and the reverse leaves revenue unclaimed. We confirm the arrangement per payer before treatment begins.
Documented attendance meeting the programme's minimum hours, the services delivered, and an authorised level of care for that date. A patient who attended briefly may not generate a billable day at all. Verifying attendance before billing prevents claims that will be reversed and gives you accurate utilisation figures for the programme.
Generally within the first business day, though it varies by plan. Late notification means early days fall outside the authorised period and are usually unrecoverable. It is an administrative loss on care that was entirely appropriate. We build the notification into the admission workflow so it happens alongside clinical intake rather than afterwards.
Not usually, if the programme rate already covers the day's services. Programme per diems typically include the counselling delivered that day, so billing sessions separately duplicates the charge. Where a service falls genuinely outside the programme structure, it may be separately billable. We check the programme definition rather than assuming.
Yes, and requirements vary considerably by state and level of care. The facility must be licensed for the levels it delivers and enrolled with each payer for those services. Missing enrollment produces denials on every day billed. Because treatment centres often add levels over time, enrollment needs updating whenever the service mix changes.
Authorised days against delivered days, plus denial reasons by review decision. That shows how much care is running outside funding and which criteria are causing losses. Centres frequently discover they lose days consistently at the same review point, which is a documentation issue they can address rather than an unavoidable cost.
We review your consent forms, testing documentation, and denied days, then show you where the constraints are costing you recoverable revenue.
Submit your details and our AAPC-certified billing auditors will coordinate a free operational audit for your clinic.
Prefer booking a direct 30-minute online calendar slot with our director of RCM?
Book Direct Meeting